Recent findings, reported on November 15, 2025, have cast a shadow over one of the most anticipated breakthroughs in ...

An oral version of semaglutide, the active ingredient in blockbuster drugs Ozempic and Wegovy, failed to slow the progression ...

For decades, scientists have targeted the sticky protein clumps that amass in Alzheimer's brains as a potential way of ...

Aperture will advance APRTX-001 as a potential treatment for ALS and frontotemporal dementia, with possible expansion for use ...

The studies offer perhaps the most concrete rebuttal yet to an idea that GLP-1 drugs, which have profound benefits on weight ...

But perhaps the larger story associated with the unsurprising result is the market reaction, as Novo's shares fell by nearly 9% at the U.S. market open Monday.

A new study, funded by Alzheimer’s Society, has identified three existing medications that could be repurposed to treat or ...

In Hawaii, 32,000 individuals live with Alzheimer's Disease. Although we do not yet have a cure, there are several new ...

News about Alzheimer's rose to the forefront in 2025, as the FDA approved the first diagnostic blood test and drugmakers ...

Novo Nordisk A/S remains a Strong Buy despite semaglutide's Alzheimer's trial miss. Click for NVO growth drivers, solid ...

Two Roswell boys are bringing their community together to help find a cure for Alzheimer's disease, and they're doing it ...

Charlie Quirke, son of actress Pauline Quirke MBE, gets set to retrace his mum’s footsteps for an emotional trek for a cure.